Click 
to remove filters
Johnson and Johnson MSD has appointed Manning Selvage and Lee (MS&L) to work on UK and international PR for anti-diarrhoea drug Imodium.
Last month, Hill and Knowlton merged its ethical and consumer healthcare divisions to create a single offering, reflecting the increasingly consumer-driven focus of the drugs market.
New Scientist has named Jeremy Webb as its new editor. He replaces Alun Anderson, who has been promoted to editor-in-chief and charged with overseeing the title s expansion into the US and on-line. The launch of a US edition and a US web site is due in March next year.
Health communications group Lowe Healthcare Worldwide has bought International Pharmaceutical Research, a contract research organisation that manages clinical trial and research programmes for the medical and biotech industries.
Procter and Gamble is understood to have selected Jackie Cooper PR from its agency roster for the UK launch of Charmin, the jumbo-sized toilet roll brand which dominates the US market.
Cohn and Wolfe has won the competitive pitch for launch PR for Zyban, Glaxo Wellcome s new smoking cessation product. The account was originally put out to tender this summer (PR Week, 16 July).
NEW YORK: Ogilvy PR Worldwide has continued its acquisition spree, buying Massachusetts-based Feinstein Kean Partners - a healthcare and biotech agency with annual fees in excess of pounds 5 million.
CHIGACO: Pharmaceuticals giant Monsanto has poached Ameritech s senior vice-president of communications, following the telecom company s takeover by rival CBS Communications.
Eli Lilly has appointed British Heart Foundation communications director Maxine Smith as its UK corporate affairs director, following the promotion of Stephen Whitehead earlier this year.
Kim Fellows has been appointed as the first Scottish public affairs director for the Association of the British Pharmaceutical Industry (ABPI), the trade body that lobbies on behalf of companies involved in the research, development and manufacture of medicines and treatments.
© Haymarket Media Group Ltd. | Terms & Conditions | Contact us